Octagon Capital Advisors is a global investment firm specializing in healthcare securities trading. The firm invests in both public and private healthcare companies worldwide, focusing on fostering long-term partnerships to support innovation. Octagon typically participates in Series A, B, and C funding rounds, with notable investments ranging from $41 million to $295 million. They manage capital on behalf of diverse global institutions, including university endowments, non-profit foundations, family offices, pension funds, and established asset managers.

Notable portfolio companies include 4D Molecular Therapeutics, Affinia Therapeutics, Aktis Oncology, and Century Therapeutics. The firm is led by key partners with extensive experience in the healthcare sector and a strong track record of successful investments. Octagon Capital's investment philosophy centers on building enduring relationships with their portfolio companies, providing strategic support to drive innovation and growth. Their value-add services include leveraging their extensive network and expertise to help portfolio companies navigate complex regulatory environments and accelerate their path to market.